Has Sandra Sacks, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,619 in general payments to Sandra Sacks, MD across 78 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sandra Sacks, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sandra Sacks, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sandra Sacks, MD

Anesthesiology · Los Angeles, CANPI 1649513110

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,694 of the $6,619 with a category attached, or 70.9%. 20 manufacturers reported payments, led by Baxter Healthcare at 29.1% of the total. 2025 is the largest year on record at $2,601, 2.4 times the $1,065 reported in 2019. Among anesthesiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,619in general payments, 2019–2025

Across 78 payments — averaging $84.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Baxter Healthcare$2K
Boston Scientific$820
Medtronic$780
Nalu Medical, Inc.$691
Abbott$483
Nevro Corp.$464
plus $1K from 14 others

What the payments were for

Consulting fees$1,92529%
Food & beverage$4,69471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Baxter Healthcare	1	$1,925
Boston Scientific	7	$820
Medtronic(2 entities)	21	$780
Nalu Medical, Inc.	7	$691
Abbott	12	$483
Nevro Corp.	3	$464
Vertos Medical, Inc.	3	$395
Painteq LLC	2	$257
Si-bone, Inc.	2	$206
MML US, Inc.	2	$171
Collegium Pharmaceutical, Inc.	7	$113
Vertex	1	$104
Relievant Medsystems, Inc.	2	$54
Stimwave Technologies Incorporated	2	$36
Biotronik NRO, Inc.	1	$33
Stryker	1	$21
Piramal Critical Care	1	$20
GSK	1	$17
West Therapeutics Development, LLC	1	$16
Arbor Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Fluid Systems - Infusion Systems$1,925
Fluid Systems - Research Devel$1,925
Nalu Neurostimulation System$611
Senza Spinal Cord Stimulation System$464
mild Device Kit$395
GENERAL PAIN MANAGEMENT$255
WaveWriter Alpha Prime 16$173
VANTA ADAPTIVESTIM$171
PAINTEQ$161
Proclaim Family of SCS IPGs$145
PROCLAIM$134
INCEPTIV$121

How this compares

$6,619 in reported general payments places this provider in the 95th percentile of 5,717 anesthesiology providers in California.

See all anesthesiology providers in California →

Medicare billing

Part B allowed, 2024

$175,134

Medicare patients

236

Services billed

1,662

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MovantikNaloxegol Oxalate	25	$14,338
Lidocaine	60	$10,027
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	189	$6,912
OxycontinOxycodone Hcl	14	$6,415
Fentanyl	83	$6,396
ZtlidoLidocaine	11	$6,376
Pregabalin	135	$5,038
Morphine Sulfate ErMorphine Sulfate	95	$4,700
Oxycodone Hcl	244	$4,208
Gabapentin	124	$2,665
Hydromorphone Hcl	76	$2,604
Scopolamine	22	$2,299
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	73	$2,054
Buprenorphine	15	$1,941
Duloxetine Hcl	53	$1,623

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Los Angeles

Maxime CannessonLos Angeles$336K
Moody MakarLos Angeles$252K
Jonathan JahrLos Angeles$223K
Michael BottrosLos Angeles$182K
David BoldtLos Angeles$153K
Natale NaimLos Angeles$66K
Anahat DhillonLos Angeles$63K
Bita FarrellLos Angeles$58K
Dane SaksaLos Angeles$52K
Emily MethangkoolLos Angeles$45K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →